
|Articles|June 20, 2019
- Pharmaceutical Commerce - June 2019
- Volume 14
- Issue 2
New reverse-logistics capacity in Illinois
Advertisement
Pharma Logistics, a longtime reverse-logistics provider, has broken ground on a new 127,000-sq. ft. facility in Libertyville, IL, near the company’s corporate offices (and near where the company was founded in 1996). The company’s reverse pharmaceutical-distribution services include rapid credit, box and ship, onsite and drug take back programs. Pharma Logistics’ clients include hospital pharmacies, the Department of Defense and Veterans Health Administration, independent pharmacies, pharmacy chains and physicians’ offices.
Articles in this issue
about 7 years ago
2019 Supplier Spotlightabout 7 years ago
Fresh technology enlivens the pharma traceability sceneabout 7 years ago
A Conversation with Greg Cathcart, Excellis Health Solutionsabout 7 years ago
A Conversation with Ara Ohanian, Systech Internationalabout 7 years ago
The Interoperability Illusionabout 7 years ago
Pharma traceability: Marching toward 2023 go-liveover 7 years ago
John Gray hangs up his spurs as head of HDAAdvertisement
Related to this article

In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.

DSCSA data exchange has matured into daily operations, but the coming NDC-12 shift and a national licensure standard add new work streams before old ones are fully settled.

Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.

Gregg Gorniak explains how AI, RFID and serialized data are helping trading partners move DSCSA compliance from a regulatory checkbox to a source of shared operational value.

As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.

Twenty-six manufacturers now hold most-favored-nation agreements, and the commitments attached to the pricing terms may matter more than the prices themselves.

Overhaul's Danny Ramon argues that quality and regulatory teams, not just logistics, need faster protocols and more accessible stability data, since stolen or compromised product that re-enters the supply chain through gray markets can ultimately reach patients.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
2
White House Extends MFN Pricing to Every State Medicaid Program
3
The PBM Entity No Pharmaceutical Company Directly Contracted With
4
How Rebate Timing Distorts a Pharmacy's 340B Books
5

